MRNA stock declined in after-hours trading following the FDA's refusal-to-file letter regarding its mRNA flu vaccine application. Here are the full details, and the key price levels traders are watching.
Atlassian stock ($TEAM) trades near 2018 prices despite revenue growing ~6x. See what’s driving the rerating, key risks, and what could revalue the stock.
APP stock jumped ahead of earnings after a key retracement eased headline risk and prompted shorts to cover. Here are the drivers, risks, and key levels to watch.
Hims & Hers stock is falling after the FDA named the company in a GLP-1 compounding crackdown, warned on marketing claims, and regulators escalated scrutiny.
Discover Takashi Kotegawa's legendary trading strategy that turned small investments into millions. Get insights to apply his approach for modern success.